Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis

被引:59
作者
Fiorillo, C
Oliviero, C
Rizzuti, G
Nediani, C
Pacini, A
Nassi, P
机构
[1] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
[2] Azienda USL 10, Lab Anal, Firenze, Italy
关键词
oxidative stress; haemodialysis;
D O I
10.1515/CCLM.1998.028
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Patients with chronic renal failure, and particularly those receiving regular haemodialysis, have a high incidence of premature cardiovascular disease. Oxidative stress, which causes lipid peroxidation, may contribute to increase the risk of atherosclerosis. The results of the present study indicate that lipid peroxidation products (malonaldehyde and 4-hydroxyalkenals) are significantly increased in plasma of renal patients before dialysis and, although reduced, remained above the normal range after this treatment. Moreover, production of free radicals and reactive oxygen metabolites was increased in chronic renal failure patients, especially after dialysis. On the other hand, the antioxidant defenses of those patients were higher than those of normal subjects, as judged from the plasma levels of specific antioxidant molecules and from the plasma antioxidant capacity. We also found that triglycerides were significantly higher in renal patients, both before and after dialysis, than in the control group. These results suggest that patients on chronic haemodialysis are particularly prone to oxidative stress and that dialysis itself may worsen this condition. Rather than to a weakening of antioxidant defenses, the susceptibility of chronic renal failure patients to oxidative stress might be ascribed to an increased free radical and reactive oxygen metabolite production and to increased levels of oxidizable substrates, notably triglycerides with their unsaturated fatty acids.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 23 条
[1]   LIPID ABNORMALITIES IN RENAL-DISEASE [J].
APPEL, G ;
SCHAEFER, E ;
MADIAS, NE ;
MADAIO, MP ;
HARRINGTON, JT ;
LEVEY, AS ;
NARAYAN, G ;
MEYER, K .
KIDNEY INTERNATIONAL, 1991, 39 (01) :169-183
[2]   LIPID AND APOLIPOPROTEIN PROFILES OF UREMIC DYSLIPOPROTEINEMIA - RELATION TO RENAL-FUNCTION AND DIALYSIS [J].
ATTMAN, PO ;
ALAUPOVIC, P .
NEPHRON, 1991, 57 (04) :401-410
[3]  
Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
[4]   Reciprocal protection of LDL and HDL oxidised by (OH)-O-center dot free radicals in the presence of oxygen [J].
BonnefontRousselot, D ;
Khalil, A ;
GardesAlbert, M ;
Delattre, J .
FEBS LETTERS, 1997, 403 (01) :70-74
[5]  
CESTARO B, 1994, BIOCHEM MOL BIOL INT, V32, P983
[6]   COMPLEMENT AND LEUKOCYTE-MEDIATED PULMONARY DYSFUNCTION IN HEMODIALYSIS [J].
CRADDOCK, PR ;
FEHR, J ;
BRIGHAM, KL ;
KRONENBERG, RS ;
JACOB, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (14) :769-774
[7]   INCREASED LIPID-PEROXIDATION IN PATIENTS ON MAINTENANCE HEMODIALYSIS [J].
DASGUPTA, A ;
HUSSAIN, S ;
AHMAD, S .
NEPHRON, 1992, 60 (01) :56-59
[8]   MORTALITY RISK-FACTORS IN PATIENTS TREATED BY CHRONIC-HEMODIALYSIS - REPORT OF THE DIAPHANE COLLABORATIVE STUDY [J].
DEGOULET, P ;
LEGRAIN, M ;
REACH, I ;
AIME, F ;
DEVRIES, C ;
ROJAS, P ;
JACOBS, C .
NEPHRON, 1982, 31 (02) :103-110
[9]  
Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
[10]  
HALLIWELL B, 1984, LANCET, V1, P1396